Author Correction Published for UNCOVERseq Gene Editing Study
A correction has been issued for a study on the UNCOVERseq method, which enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities.
The story so far
2 publishers have covered this in 3 articles since 12 Oct 2026. Nature Communications published first, on 12 October at 00:00 UTC; Phys.org - latest science and technology news stories followed 69h 00m later. The most recent article, from Phys.org - latest science and technology news stories, appeared on 14 October at 21:00 UTC.
Outlets reporting it: Nature Communications (major outlet), Phys.org - latest science and technology news stories.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
- Nature CommunicationsAuthor Correction: UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems
- Nature CommunicationsAuthor Correction: Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing
- Phys.org - latest science and technology news storiesEngineered enzyme could improve detection of HIV and other viruses
Sources
Every article we clustered into this story. Headlines link to the publisher.
- Author Correction: Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing Nature Communications ·
- Author Correction: UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems Nature Communications ·
- Engineered enzyme could improve detection of HIV and other viruses Phys.org - latest science and technology news stories